Published in J Clin Pathol on April 01, 2009
Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn (2011) 2.57
Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol (2012) 2.28
DNA methylation as a universal biomarker. Expert Rev Mol Diagn (2010) 1.18
MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease. Pharmacol Ther (2011) 1.03
Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods (2012) 0.98
A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device. J Clin Lab Anal (2013) 0.96
Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health (2015) 0.96
MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics. Int J Mol Epidemiol Genet (2011) 0.88
Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC). PLoS One (2016) 0.85
Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications. Genome Med (2012) 0.82
Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J (2010) 0.81
Reliable detection of paternal SNPs within deletion breakpoints for non-invasive prenatal exclusion of homozygous α-thalassemia in maternal plasma. PLoS One (2011) 0.80
Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer. PeerJ (2016) 0.77
Comparative transcriptome analysis reveals early pregnancy-specific genes expressed in peripheral blood of pregnant sows. PLoS One (2014) 0.75
Getting to know the fetal genome non-invasively: now a reality. Protein Cell (2012) 0.75
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem (2012) 3.35
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. Br J Cancer (2007) 1.22
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer (2004) 1.15
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet (2004) 1.00
Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet (2003) 0.99
Nuclear beta-catenin expression is rare and its potential association with short survival in colorectal signet-ring cell carcinoma. Appl Immunohistochem Mol Morphol (2005) 0.89
Circulating nucleic acid analysis: diagnostic applications for acute pathologies. Acta Neurochir Suppl (2005) 0.79
Nuclear beta-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form. J Clin Pathol (2006) 0.77
Evidence of circulating donor genetic material in bone allotransplantation. Int J Mol Med (2006) 0.76
Circulating nucleic acids as a tumor marker. Histol Histopathol (2002) 0.76
Proteomic profiling in SARS: diagnostic and prognostic applications. Hong Kong Med J (2009) 0.75